New Corporate Deal Models for Medtech Companies
New Corporate Deal Models for Medtech Companies
Often continuous internal innovation is expensive and unpredictable for medtech companies, and yet in order to continue to grow their business, they need to introduce important new products. A panel at 2016 WSGR Medical Device Conference, discussed what large companies are looking for today and how evolving deal structures can benefit both the buyer and the seller. The panelists discussed this…
View On WordPress













